No Data
Overview of the lifting of the lock-up restrictions on A-shares | April 30
According to Zhitong Finance APP, on April 30, there were a total of 4 listed companies' restricted shares released, with a total market value of approximately 1.519 billion yuan. The specific conditions of the restricted share releases today are as follows: Stock abbreviation Stock code Type of restricted shares Number of released shares Ningxia Orient Tantalum Industry 000962 Additional A-shares Institutional allocation 4.4622 million Zhuhai Huafa Properties 600325 Additional A-shares Original shareholders allocation 0.181 billion Deguan New Materials 001378 Extended restriction lock-up period Circulation 2.837 million Haoyuan Pharmaceutical 688131 3.2435 million.
Haoyuan Pharmaceutical: Report of Shanghai Haoyuan Pharmaceutical Co., Ltd. for the first quarter of 2025
Shanghai Haoyuan Pharmaceutical Co., Ltd. Report for the first quarter of 2025
Haoyuan Pharmaceutical: 2024 Annual Report of Shanghai Haoyuan Pharmaceutical Co., Ltd. (updated)
Shanghai Haoyuan Pharmaceutical Co., Ltd. 2024 Annual Report (updated)
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) P/E Is Still On The Mark Following 31% Share Price Bounce